A District advisory committee OK’d bids from Johns Hopkins Medicine and MedStar Health to build costly proton therapy centers on Thursday, leaving both just one step from final approval to proceed on the high-tech cancer treatment programs.
It wasn’t, however, a clean victory for either. The committee rejected a key part of Hopkins’ plan and asked for additional details about both nonprofit system’s outreach to under-served neighborhoods.